医薬市場の調査会社として定評を得ておりますEspicom Business Intelligence（本社：英国）では、企業および製品に関する最新情報を収めた24〜28ページの英文ニューズレター "Medical Industry Week" を毎週発行しています。

当ニューズレターでは競争の激しい世界の医療機器市場を独自の観点からとらえ、次のような内容で詳細にレポートしていきます。

企業ニュース 最近の買収 合併/分割 訴訟 リストラ 投資 契約（協定）ニュース 医療機器分野の企業・団体間でなされた主要な契約（協定）の詳細 財務ニュース 四半期/半期/年度ごとの財務実績 製品ニュース 製品導入 整理 申請 研究開発ニュース 新技術 特許 開発 臨床試験

Abstract

This in-depth and easy to read publication provides a unique perspective on the competitive worldwide medical device market.

Regular sections in Medical Industry Week include:

Corporate News - The latest acquisitions, mergers, divestitures, litigation, restructuring and investment news.

Agreement News - Full details of major agreements between companies and organisations in the medical device field.

Financial News - Quarterly, half-yearly and yearly financial results and performance are regularly brought into the spotlight in an easy-to-read format.

Product News - MIW reports on the latest product introductions, clearances and filings of medical devices and equipment worldwide.

R&D News - New technologies, patents, developments and clinical trials are closely monitored.

Medical Industry Week (MIW) delivers more corporate news than any other business publication, and is fast becoming the information source of choice for manufacturers, suppliers, commerce, investors and regulators - make sure you get the benefits too!

MIW is available in print, email (pdf) and web formats. The web version of MIW provides you with a daily updated news service, while the pdf & paper issues provide a weekly digest.

Table of Contents

• Centerpulse accepts £1.5 billion offer from S&N
• CORPORATE NEWS
• Biocompatibles agrees settlement with Isostent
• Bausch & Lomb/CIBA Vision patent battle reaches Ireland
• UK' s OFT makes final decision on Coloplast/SSL transaction
• Guidant to acquire Biosensors' everolimus-eluting stent programme
• Tds targets telemedicine opportunities in the UK and US
• Integra buys manufacturer of surgical instruments
• CORPORATE NEWS IN BRIEF
• AGREEMENT NEWS
• Accuray agrees CyberKnife purchase and placement contracts
• Boston Scientific and Osiris to develop and commercialise MSC technology
• Extension of agreement to evaluate Antares Pharma' s mini-needle technology
• GE subsidiary signs pact with Edwards Lifesciences
• Siemens helps develop all-digital healthcare facility in Temple, TX
• GEMS/EMC provide integrated healthcare solutions
• Nellcor agrees supply contract with Consorta
• Wright Medical extends links with LifeCell
• AGREEMENT NEWS IN BRIEF
• FINANCIAL NEWS
• Smiths Medical maintains growth despite increased R&D spending
• Analogic announces record quarterly sales and earnings
• Tyco pursues aggressive cost cutting programme; internal review highlights “issues” in core division
• New product introductions drive growth for Essilor
• Centerpulse forecasts growth in core markets
• FINANCIAL NEWS IN BRIEF
• PRODUCT NEWS
• Profile Therapeutics offers new device for delivering nebulised antibiotics to CF patients
• Cook offers new product for inguinal hernia repair.
• BioElectronics' soft tissue therapy patch approved for US distribution
• FDA approves Inamed' s new dermal filler products
• FDA clears new series of Imbibe syringes
• Three new products launched to enhance vaccination safety
• FDA approves reprocessing medical devices by Alliance Medical
• HealthTronics cleared to market new device for chronic lateral epicondylitis
• Tyco unit offers new nasal CPAP systems
• Datex-Ohmeda offers new solutions for accessing clinical information
• TissueLink widens scope for proprietary technology.
• Siemens unveils new patient monitoring systems at
• ISICEM
• CPC is cleared to market counterpulsation device using non-compressed air.
• PRODUCT NEWS IN BRIEF
• R&D NEWS
• Boston Scientific' s TAXUS programme granted expedited review" status by the FDA
• Medicare panel backs reimbursement coverage for LVADs.
• NMT Medical' s CLOSURE 1 trial gains conditional approval
• Aradigm' s AERx iDMS produces reproducible dosing in asthmatics and smokers
• Curon releases data from clinical trial of GORD treatment.
• First US-based “robotic” catheterisation procedure with Stereotaxis technology completed
• Provectus tests laser treatment for ocular melanoma
• TheraCyte to use human cell lines in diabetes implant treatment
• R&D NEWS IN BRIEF
• TABLE OF CONTENTS
• COMPANY INDEX